Fidelity, Biogen, Sanofi Join $45M Bet on Alzheimer's and Parkinson's Startup

February 10, 2016 | The drug industry is pouring billions into R&D against Alzheimer's disease. Yet many people in the business will tell you not nearly enough is known about the underlying biology. Forbes